SUSTAINABILITY. From now onwards, the registrations for Act Sustainable are open. Don´t forget that each event requires its own registration, but you can register for as many events as you want. For those of you who are students or employees at Chalmers University of Technology or the University of Gothenburg, you will participate in the events via Zoom. It gives you the opportunity for active participation, for example by asking…
Thomas Karikari recognized for best scholarly article
AWARD. Thomas Karikari, a researcher in clinical neurochemistry at the University of Gothenburg, is one of this year’s recipients of the Fondkistan Foundation scholarship that the Swedish Alzheimer’s Foundation awards to promising young researchers. The award was presented on September 21 during the live broadcast of the Alzheimer’s Foundation event on International Alzheimer’s Day, in which several other leading dementia researchers from Gothenburg also participated. This year two promising young…
Universeum’s SEK 50m donation from Krefting Foundation
INTERACTION. Universeum science center in Gothenburg is to receive SEK 7 million from the Herman. Krefting Foundation for Allergy and Asthma Research, the principal owner of the VBG Group. The donation kicks off Universeum’s life science venture, the initial phase being a new learning environment developed with the Krefting Research Center. This collaboration with the Krefting Foundation will continue until 2026 and the donations will total some SEK 50 million…
Researchers once again answer questions from the people of Gothenburg on the radio – Alltinget is back
COLUMN. After an eight-year hiatus, the Alltinget program is now back on the radio. The program came to an end when program director Lasse Swahn retired, but now he and the panel are back again every other week during the spring on Swedish Radio’s P4 channel in Gothenburg. In this column, panel member Henrik Sjövall gives us some behind-the-scenes insight from the new launch of the program. You can hear…
Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator Makes Major Investment to Fast Track Development of Novel Biomarkers
GRANT. Professor Henrik Zetterberg at the University of Gothenburg will head a major European research collaboration, which is developing a significantly easier way to diagnose Alzheimer’s disease at an early stage through a blood test. Such a test could offer the potential for developing new treatments for Alzheimer’s and related dementias. . Through its Diagnostics Accelerator, the Alzheimer’s Drug Discovery Foundation (ADDF) – a U.S. based non-profit – is committed…